Other Lupus News

September 17, 2014

The last 21st Century Cures roundtable held in Washington last week discussed opportunities to accelerate the discovery, development, and delivery of new cures and treatments. NIH Director Dr. Francis Collins talked about the Accelerating Medicine Partnership which is working toward cures for lupus and other chronic diseases.

September 9, 2014

Yale Cancer Center researchers recently published findings showing a possible way to use lupus antibodies to “sabotage” certain cancer cells. The study found that those cancer cells unable to repair damage to their own DNA were “significantly more vulnerable to attack by lupus antibodies.”

July 2, 2014

Animal research shows that an investigational drug that blocks the enzyme Cdk5 might help reduce the injury that can result following a stroke, a potential complication of lupus.

June 30, 2014

The FDA has granted Breakthrough Therapy Designation to idarucizumab, a potential antidote for the anticoagulant Pradaxa. Many lupus patients receive anticoagulation; new oral anticoagulants like Pradaxa are effective but can be dangerous because their anticoagulant event cannot be reversed if patients start to bleed.